Capital eventCH· 1mo ago
Lausanne-based Adaptyv raises €34.35 million Series A to build the automated lab for agentic biology - Houston News Network
Adaptyv Bio, a Lausanne-based biotech startup building an automated wet lab for AI-driven protein design, raised €34.35 million in a Series A led by Highland Europe, with continued support from Ace Ventures, ByFounders, Y Combinator, and others, signaling bolstered funding and potential expansion in automated biology capabilities.
houstonnewsnetwork.com ↗venture
Intent
WARM· 55intent / 100
▸ why this score▾ score breakdown
- default: P(contract_to_capital_90d) · p=0.37 × w=3.0+1.1
- default: OON discount · × 0.75-0.4
- Final score (ambiguity-dampened) · default=55+55
- V2 winner: default · default=55+0
Go-to-market brief
Daily 5 RWA signals
Five signals in your inbox each morning. Email only.
Free. The daily 5 lands at 07:00 UTC, nothing else. One-click unsubscribe in every email.